These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 19248873

  • 1. [Prevalence of left ventricular hypertrophy, atrial fibrillation and cardiovascular disease in hypertensive patients of Andalusia, Spain. PREHVIA study].
    Martín-Rioboó E, García Criado E, Pérula De Torres LA, Cea-Calvo L, Anguita Sánchez M, López Granados A, Ureña Fernández T, García Matarín L, Molina Díaz R, en representación del Grupo de Hipertensión Arterial de la Sociedad Andaluza de Medicina Familiar y Comunitaria (SAMFyC) y de los investigadores del estudio PREHVIA.
    Med Clin (Barc); 2009 Feb 28; 132(7):243-50. PubMed ID: 19248873
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Regression of electrocardiographic left ventricular hypertrophy or strain is associated with lower incidence of cardiovascular morbidity and mortality in hypertensive patients independent of blood pressure reduction - A LIFE review.
    Bang CN, Devereux RB, Okin PM.
    J Electrocardiol; 2014 Feb 28; 47(5):630-5. PubMed ID: 25052475
    [Abstract] [Full Text] [Related]

  • 5. Detection of left ventricular hypertrophy by different electrocardiographic criteria in clinical practice. Findings from the Sara study.
    Calderón A, Barrios V, Escobar C, Ferrer E, Barrios S, González-Pedel V, Montoro P, Navarro-Cid J.
    Clin Exp Hypertens; 2010 May 28; 32(3):145-53. PubMed ID: 20504121
    [Abstract] [Full Text] [Related]

  • 6. Relationship of left atrial enlargement to persistence or development of ECG left ventricular hypertrophy in hypertensive patients: implications for the development of new atrial fibrillation.
    Okin PM, Gerdts E, Wachtell K, Oikarinen L, Nieminen MS, Dahlöf B, Devereux RB.
    J Hypertens; 2010 Jul 28; 28(7):1534-40. PubMed ID: 20589977
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prognostic impact of baseline and serial changes in electrocardiographic left ventricular hypertrophy in resistant hypertension.
    Salles GF, Cardoso CR, Fiszman R, Muxfeldt ES.
    Am Heart J; 2010 May 28; 159(5):833-40. PubMed ID: 20435193
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study.
    Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS, Snapinn S, Harris KE, Aurup P, Edelman JM, Dahlof B, Losartan Intervention for Endpoint reduction in hypertension Study Investigations.
    Circulation; 2003 Aug 12; 108(6):684-90. PubMed ID: 12885747
    [Abstract] [Full Text] [Related]

  • 14. Electrocardiographic left ventricular hypertrophy regression induced by an angiotensin receptor blocker-based regimen in hypertensive patients with diabetes: data from the SARA study.
    Barrios V, Escobar C, Calderón A, Echarri R, Barrios S, Navarro-Cid J.
    J Renin Angiotensin Aldosterone Syst; 2009 Sep 12; 10(3):168-73. PubMed ID: 19651760
    [Abstract] [Full Text] [Related]

  • 15. Association of electrocardiographic and imaging surrogates of left ventricular hypertrophy with incident atrial fibrillation: MESA (Multi-Ethnic Study of Atherosclerosis).
    Chrispin J, Jain A, Soliman EZ, Guallar E, Alonso A, Heckbert SR, Bluemke DA, Lima JA, Nazarian S.
    J Am Coll Cardiol; 2014 May 20; 63(19):2007-13. PubMed ID: 24657688
    [Abstract] [Full Text] [Related]

  • 16. Standard electrocardiographic criteria for left ventricular hypertrophy in Nigerian hypertensives.
    Dada A, Adebiyi AA, Aje A, Oladapo OO, Falase AO.
    Ethn Dis; 2005 May 20; 15(4):578-84. PubMed ID: 16259479
    [Abstract] [Full Text] [Related]

  • 17. [Left ventricular hypertrophy in the Spanish hypertensive population. The ERIC-HTA study].
    Lozano JV, Redón J, Cea-Calvo L, Fernández-Pérez C, Navarro J, Bonet A, González-Esteban J.
    Rev Esp Cardiol; 2006 Feb 20; 59(2):136-42. PubMed ID: 16540035
    [Abstract] [Full Text] [Related]

  • 18. Metabolic syndrome, organ damage and cardiovascular disease in treated hypertensive patients. The ERIC-HTA study.
    Navarro J, Redón J, Cea-Calvo L, Lozano JV, Fernández-Pérez C, Bonet A, González-Esteban J.
    Blood Press; 2007 Feb 20; 16(1):20-7. PubMed ID: 17453748
    [Abstract] [Full Text] [Related]

  • 19. Kidney function and cardiovascular disease in the hypertensive population: the ERIC-HTA study.
    Redón J, Cea-Calvo L, Lozano JV, Fernández-Pérez C, Navarro J, Bonet A, González-Esteban J, ERIC-HTA 2003 Study Investigators.
    J Hypertens; 2006 Apr 20; 24(4):663-9. PubMed ID: 16531794
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.